Drugs / Etonogestrel/ethinyl estradiol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04257500 | Sep 2020 → Aug 2025 | polycystic ovary syndrome | Andrea Roe, MD, MPH | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Etonogestrel/ethinyl estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04257500 ↗ |